@article{JTD20376,
author = {Habeeb Majeed and Eitan Amir},
title = {Personalized medicine in immuno-oncology: a novel prognostic index in non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 9},
year = {2018},
keywords = {},
abstract = {Immune checkpoint inhibitors have revolutionized the treatment of selected cancers with meaningful survival improvement in melanoma (1), renal cell carcinoma (2), and non-small cell lung cancer (NSCLC) (3-5). Despite these advances, a substantial proportion of patients do not benefit from treatment.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/20376}
}